203 related articles for article (PubMed ID: 38495785)
1. Associations between type 2 diabetes mellitus and chronic liver diseases: evidence from a Mendelian randomization study in Europeans and East Asians.
Zhao Y; Li D; Shi H; Liu W; Qiao J; Wang S; Geng Y; Liu R; Han F; Li J; Li W; Wu F
Front Endocrinol (Lausanne); 2024; 15():1338465. PubMed ID: 38495785
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the role of non-alcoholic fatty liver disease in cardiovascular diseases and type 2 diabetes: a Mendelian randomization study in Europeans and East Asians.
Au Yeung SL; Borges MC; Wong THT; Lawlor DA; Schooling CM
Int J Epidemiol; 2023 Jun; 52(3):921-931. PubMed ID: 36367831
[TBL] [Abstract][Full Text] [Related]
3. Inverse association between type 2 diabetes and hepatocellular carcinoma in East Asian populations.
Huo J; Xu Y; Chen X; Yu J; Zhao L
Front Endocrinol (Lausanne); 2023; 14():1308561. PubMed ID: 38234424
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic fatty liver disease and type 2 diabetes: an observational and Mendelian randomization study.
Yu Y; Yu Y; Wang Y; Chen Y; Wang N; Wang B; Lu Y
Front Endocrinol (Lausanne); 2023; 14():1156381. PubMed ID: 37223039
[TBL] [Abstract][Full Text] [Related]
5. Type 1 diabetes mellitus and non-alcoholic fatty liver disease: a two-sample Mendelian randomization study.
Tuo L; Yan LT; Liu Y; Yang XX
Front Endocrinol (Lausanne); 2024; 15():1315046. PubMed ID: 38681765
[TBL] [Abstract][Full Text] [Related]
6. Impact of diabetes, obesity, and dyslipidemia on the risk of hepatocellular carcinoma in patients with chronic liver diseases.
Shin HS; Jun BG; Yi SW
Clin Mol Hepatol; 2022 Oct; 28(4):773-789. PubMed ID: 35934813
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus infection and the risk of liver disease progression in type 2 diabetic patients with potential nonalcoholic fatty liver disease: a retrospective, observational, cohort study in the United Kingdom Clinical Practice Research Datalink.
Ferreira G; Stuurman AL; Horsmans Y; Cattaert T; Verstraeten T; Feng Y; Rosillon D; Guignard A
Eur J Gastroenterol Hepatol; 2020 Jan; 32(1):101-109. PubMed ID: 31651649
[TBL] [Abstract][Full Text] [Related]
8. Causal linkage between type 2 diabetes mellitus and inflammatory bowel disease: an integrated Mendelian randomization study and bioinformatics analysis.
Xiao X; Wu X; Yi L; You F; Li X; Xiao C
Front Endocrinol (Lausanne); 2024; 15():1275699. PubMed ID: 38313367
[TBL] [Abstract][Full Text] [Related]
9. Causal effects of inflammatory bowel disease on risk of type 2 diabetes: a two-sample multivariable Mendelian randomization study.
Niu Y; Zhang Q; Wei Y
Acta Diabetol; 2024 Jun; 61(6):715-724. PubMed ID: 38427067
[TBL] [Abstract][Full Text] [Related]
10. Association between diabetes mellitus and primary biliary cholangitis: a two-sample Mendelian randomization study.
Lv D; Wang H; Leng Y; Chen S; Sun H; Meng X; Liu T; Xiong Z
Front Endocrinol (Lausanne); 2024; 15():1362584. PubMed ID: 38774228
[TBL] [Abstract][Full Text] [Related]
11. A two-sample mendelian randomization analysis excludes causal relationships between non-alcoholic fatty liver disease and kidney stones.
Li X; Xie Y; Tang L; Li D; Wang J; Sheng H; Chen K; Xiao S; Li J; Yang M
Front Endocrinol (Lausanne); 2023; 14():1343367. PubMed ID: 38269249
[TBL] [Abstract][Full Text] [Related]
12. Investigating causal associations among gut microbiota, metabolites, and liver diseases: a Mendelian randomization study.
Zhang L; Zi L; Kuang T; Wang K; Qiu Z; Wu Z; Liu L; Liu R; Wang P; Wang W
Front Endocrinol (Lausanne); 2023; 14():1159148. PubMed ID: 37476494
[TBL] [Abstract][Full Text] [Related]
13. Associations of non-alcoholic fatty liver disease and cirrhosis with liver cancer in European and East Asian populations: A Mendelian randomization study.
Deng Y; Huang J; Wong MCS
Cancer Rep (Hoboken); 2024 Jan; 7(1):e1913. PubMed ID: 37840448
[TBL] [Abstract][Full Text] [Related]
14. The causal relationship between gut microbiota and type 2 diabetes: a two-sample Mendelian randomized study.
Sun K; Gao Y; Wu H; Huang X
Front Public Health; 2023; 11():1255059. PubMed ID: 37808975
[TBL] [Abstract][Full Text] [Related]
15. Increased prevalence but decreased survival of nonviral hepatocellular carcinoma compared to viral hepatocellular carcinoma in recent ten years.
Chen TC; Hsiao SW; Chen YY; Yen HH; Su WW; Hsu YC; Huang SP; Su PY
Sci Rep; 2024 Apr; 14(1):9068. PubMed ID: 38643245
[TBL] [Abstract][Full Text] [Related]
16. Causal associations between liver enzymes and diabetic microvascular complications: A univariable and multivariable Mendelian randomization.
Li Y; Zhang Q
PLoS One; 2024; 19(1):e0296894. PubMed ID: 38232082
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B infection is causally associated with extrahepatic cancers: A Mendelian randomization study.
Kamiza AB; Fatumo S; Singini MG; Yeh CC; Chikowore T
EBioMedicine; 2022 May; 79():104003. PubMed ID: 35447390
[TBL] [Abstract][Full Text] [Related]
18. Estimating causal effects of genetically predicted type 2 diabetes on COVID-19 in the East Asian population.
Yoshikawa M; Asaba K; Nakayama T
Front Endocrinol (Lausanne); 2022; 13():1014882. PubMed ID: 36568068
[TBL] [Abstract][Full Text] [Related]
19. Non-alcoholic fatty liver disease and gestational diabetes mellitus: a bidirectional two-sample mendelian randomization study.
Zhou BG; Xia JL; Jiang X; Ding YB; She Q
BMC Endocr Disord; 2024 Mar; 24(1):40. PubMed ID: 38504196
[TBL] [Abstract][Full Text] [Related]
20. Relationship between the rs2596542 polymorphism in the MICA gene promoter and HBV/HCV infection-induced hepatocellular carcinoma: a meta-analysis.
Luo X; Wang Y; Shen A; Deng H; Ye M
BMC Med Genet; 2019 Aug; 20(1):142. PubMed ID: 31419949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
